Pharmacovigilance Market 2021-2031: Analyzed By Business Growth, Development Factors, Applications, And Future Prospects

 ESOMAR-certified company Future Market Insights (FMI) has published a report on the global pharmacovigilance market for the forecast period 2021-2031. According to the report, the market is poised to reach new heights, as pharmaceutical companies scramble to introduce new drug candidates for multiple ailments, which will result in an increase in clinical trials.

As per FMI’s analysis, the market is expected to register double-digit growth, experiencing an impressive CAGR throughout the forecast period. Historically, the market posted credible gains, surpassing US$ 6 billion in 2020, expanding at a CAGR of over 14%. Growth prospects were further heightened during the COVID-19 pandemic, as the scramble for new treatment approaches is prompting pharmaceutical companies to initiate clinical trials for the same.

Prominent pharmaceutical companies are forging long-term partnerships and service agreements with contract research organizations and business processing outsourcing units to enhance existing pharmacovigilance operations by virtue of cost reduction from drug delivery to post-marketing approvals. In April 2021, Thermo Fisher Scientific Inc. announced its plans to acquire Pharmaceutical Product Development (PPD) Inc. for a purchase price of US$ 17.4 billion, which will help enhance the latter’s pharmacovigilance portfolio expansion.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1107

Key Takeaways from FMI’s Pharmacovigilance Market Study

  • By phase of drug development, stage IV clinical trials pharmacovigilance solutions account for over 3 out of 4 applications
  • Based on method type, targeted spontaneous reporting to make maximum use of pharmacovigilance solutions
  • By service provider type, contract outsourcing to generate almost two out of five pharmacovigilance solutions uptake
  • US experiencing robust pharmacovigilance solutions providers presence amid prevalence of good PV practices
  • Forthcoming clinical trials for numerous drug candidates through 2021 to widen UK’s growth prospects
  • India to emerge as an emerging pharmacovigilance hub amid growing trends of medical operations outsourcing
  • China to experience growth on the back of recent amendments to render pharmacovigilance implementation stronger

“Rising prevalence of chronic and infectious ailments is prompting multiple pharmaceutical giants to initiate widespread clinical trials for potential drug molecules, generating a highly competitive environment and generating major revenue pools,” says the FMI analyst.

Competitive Landscape

Prominent pharmacovigilance solutions providers are relying on collaborating with prominent biopharmaceutical and pharmaceutical companies to offer their digital solutions to facilitate effective patient care solutions. Also, offering advanced solutions is another prominent strategy. Some prominent faces include F. Hoffmann- La Roche, GlaxoSmithKline Plc., Covance Inc., ICON Plc. and iGATE Corporation among others.

Covance Inc. is a prominent pharmacovigilance solutions providing, offering end-to-end PV services spanning clinical and post-marketing phases from medical contract centers to ICSRs to medical reviews to electronic regulatory submissions. The system helps track weekly, daily and monthly metrics for quality, productivity and efficiency.

In April 2020, ICON Plc. initiated efforts to enhance pharmacovigilance practices, considering the onset of COVID-19. A webinar conducted on this issue by the company called for key pharmaceutical companies to automate their workflows by installing proactive and dedicated intelligence processes, forging detailed business and continuity plans and a virtually globally distributed footprint.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1107

More Insights on the Global Pharmacovigilance Market

In its latest report, FMI offers an unbiased analysis of the global pharmacovigilance market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of phase of drug development (preclinical studies, phase I, phase II, phase III and phase IV), type of methods (spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring and EHR mining), service type provider (in-house pharmacovigilance and contract outsourcing) and region (North America, Latin America, Europe, Asia-Pacific and Middle East & Africa).

Comments

Post a Comment

Popular posts from this blog

Chewable Energy Tablet Market Potential Growth, Share, Demand and Analysis of Key Players — Forecasts to 2034

 The global  chewable energy tablet market  value is estimated to total  US$ 478.9 million  in 2024. It will likely exhibit a CAGR of  8.9%  throughout the forecast period, totaling a valuation of  US$ 1,120.6 million  by 2034. Consumers mostly prefer orange-flavored chewable energy tablets owing to their perceived health benefits and other advantages. As per the latest analysis, the orange flavor segment will likely progress at a CAGR of  5.6%  through 2034. Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-19020 Several factors are predicted to fuel the growth of the chewable energy tablet industry during the assessment period. These include: Increasing demand for convenient and portable energy sources Growing health consciousness Rising preference of fitness enthusiasts towards chewable energy products Escalating  demand for functional foods Ava...
Read more

Canned Soup Market Growth Opportunities, Industry Analysis, Size, Share, Geographic Segmentation & Competitive Landscape Report To 2032

 The  canned soup market  is witnessing significant growth in recent years due to the convenience it offers to consumers. Canned soups are a quick and easy meal option, saving time and effort in the kitchen. With an increasing number of working individuals and busy lifestyles, the demand for ready-to-eat meals is soaring. Additionally, the pandemic has further driven the market, as people seek shelf-stable, long-lasting food options during lockdowns. The global canned soup market is anticipated to rise at a CAGR of 6.6% over the projected period, reaching a market value of US$ 2.8 Bn by 2022. Furthermore, consumers prefer canned soup products to alternative protein sources because of benefits such as balanced macro and micronutrients, as well as high protein content. As the consumption of processed foods is increasing across the globe, the demand in the market is expected to surge. Dive into the dynamic world of the Canned Soup Market with our exclusive Sa...
Read more

Moringa Tea Market Size 2024 Global Industry Share, Top Players, Opportunities And Forecast To 2034

 The global  moringa tea market  size to record a valuation of US$ 8,001.40 million in 2024. Looking ahead to 2034, the current forecast projects a CAGR of 10.40% throughout. Current projections of the moringa tea industry imply a valuation of US$ 21,456.10 million by 2034. Impelling Causes Bolstering Moringa Tea Demand Owing to its health benefits, moringa tea is a proliferating trend among other tea beverages on the market, such as the well-known matcha tea. The market niche of moringa tea is evolving due to its appeal to tea lovers and health-conscious consumers. Moringa tea stands out from other tea products due to its high nutritious content and lack of caffeine. Among the products made from moringa are oil, tea, seeds, and other health-related items. The global moringa tea market is augmenting due to the ease with which raw materials can be obtained and the extensive network of exporters of moringa tea. Request a Sample Report!  https://www.futuremarket...
Read more